{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:56:36Z","timestamp":1791464196728,"version":"4.3.4"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T00:00:00Z","timestamp":1664236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T00:00:00Z","timestamp":1664236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Center For Advancing Translational Sciences of the National Institutes of Health","award":["UL1TR002553"],"award-info":[{"award-number":["UL1TR002553"]}]},{"DOI":"10.13039\/100008648","name":"Pfizer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008648","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Duke Clinical and Translational Science Institute"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurocrit Care"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s12028-022-01599-9","type":"journal-article","created":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T20:19:36Z","timestamp":1664309976000},"page":"345-355","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Evaluation of Levetiracetam Dosing Strategies for Seizure Prophylaxis Following Traumatic Brain Injury"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4248-5838","authenticated-orcid":false,"given":"Kelsey","family":"Ohman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridgette","family":"Kram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Schultheis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Sigmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safa","family":"Kaleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zidanyue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Jie","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cory","family":"Vatsaas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Komisarow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,27]]},"reference":[{"issue":"1","key":"1599_CR1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1227\/NEU.0000000000001432","volume":"80","author":"N Carney","year":"2017","unstructured":"Carney N, Totten AM, O\u2019Reilly C, et al. Guidelines for the management of severe traumatic brain injury. Neurosurgery. 2017;80(1):6\u201315. https:\/\/doi.org\/10.1227\/NEU.0000000000001432.","journal-title":"Neurosurgery"},{"issue":"5","key":"1599_CR2","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1111\/j.1528-1167.2009.02384.x","volume":"51","author":"PL Ferguson","year":"2010","unstructured":"Ferguson PL, Smith GM, Wannamaker BB, Thurman DJ, Pickelsimer EE, Selassie AW. A population-based study of risk of epilepsy after hospitalization for traumatic brain injury. Epilepsia. 2010;51(5):891\u20138. https:\/\/doi.org\/10.1111\/j.1528-1167.2009.02384.x.","journal-title":"Epilepsia"},{"issue":"8","key":"1599_CR3","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJM199008233230801","volume":"323","author":"NR Temkin","year":"1990","unstructured":"Temkin NR, Dikmen SS, Wilensky AJ, Keihm J, Chabal S, Winn HR. A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures. N Engl J Med. 1990;323(8):497\u2013502. https:\/\/doi.org\/10.1056\/NEJM199008233230801.","journal-title":"N Engl J Med"},{"issue":"11","key":"1599_CR4","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1177\/1060028014549013","volume":"48","author":"WM Gabriel","year":"2014","unstructured":"Gabriel WM, Rowe AS. Long-term comparison of GOS-E scores in patients treated with phenytoin or levetiracetam for posttraumatic seizure prophylaxis after traumatic brain injury. Ann Pharmacother. 2014;48(11):1440\u20134. https:\/\/doi.org\/10.1177\/1060028014549013.","journal-title":"Ann Pharmacother"},{"issue":"4","key":"1599_CR5","doi-asserted-by":"publisher","first-page":"E3","DOI":"10.3171\/FOC.2008.25.10.E3","volume":"25","author":"KE Jones","year":"2008","unstructured":"Jones KE, Puccio AM, Harshman KJ, et al. Levetiracetam versus phenytoin for seizure prophylaxis in severe traumatic brain injury. Neurosurg Focus. 2008;25(4):E3. https:\/\/doi.org\/10.3171\/FOC.2008.25.10.E3.","journal-title":"Neurosurg Focus"},{"issue":"6","key":"1599_CR6","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1227\/NEU.0000000000001445","volume":"79","author":"NR Khan","year":"2016","unstructured":"Khan NR, VanLandingham MA, Fierst TM, et al. Should levetiracetam or phenytoin be used for posttraumatic seizure prophylaxis? A Systematic review of the literature and meta-analysis. Neurosurgery. 2016;79(6):775\u201382. https:\/\/doi.org\/10.1227\/NEU.0000000000001445.","journal-title":"Neurosurgery"},{"issue":"5","key":"1599_CR7","doi-asserted-by":"publisher","first-page":"883.e9","DOI":"10.1016\/j.jcrc.2012.11.020","volume":"28","author":"RM Kruer","year":"2013","unstructured":"Kruer RM, Harris LH, Goodwin H, et al. Changing trends in the use of seizure prophylaxis after traumatic brain injury: a shift from phenytoin to levetiracetam. J Crit Care. 2013;28(5):883.e9-13. https:\/\/doi.org\/10.1016\/j.jcrc.2012.11.020.","journal-title":"J Crit Care"},{"key":"1599_CR8","doi-asserted-by":"publisher","first-page":"e901","DOI":"10.1016\/j.wneu.2017.11.116","volume":"110","author":"CD Wilson","year":"2018","unstructured":"Wilson CD, Burks JD, Rodgers RB, Evans RM, Bakare AA, Safavi-Abbasi S. Early and late posttraumatic epilepsy in the setting of traumatic brain injury: a meta-analysis and review of antiepileptic management. World Neurosurg. 2018;110:e901\u20136. https:\/\/doi.org\/10.1016\/j.wneu.2017.11.116.","journal-title":"World Neurosurg"},{"issue":"3","key":"1599_CR9","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1097\/TA.0b013e3182826e84","volume":"74","author":"K Inaba","year":"2013","unstructured":"Inaba K, Menaker J, Branco BC, et al. A prospective multicenter comparison of levetiracetam versus phenytoin for early posttraumatic seizure prophylaxis. J Trauma Acute Care Surg. 2013;74(3):766\u201371. https:\/\/doi.org\/10.1097\/TA.0b013e3182826e84.","journal-title":"J Trauma Acute Care Surg"},{"issue":"2","key":"1599_CR10","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s12028-009-9304-y","volume":"12","author":"JP Szaflarski","year":"2010","unstructured":"Szaflarski JP, Sangha KS, Lindsell CJ, Shutter LA. Prospective, randomized, single-blinded comparative trial of intravenous levetiracetam versus phenytoin for seizure prophylaxis. Neurocrit Care. 2010;12(2):165\u201372. https:\/\/doi.org\/10.1007\/s12028-009-9304-y.","journal-title":"Neurocrit Care"},{"key":"1599_CR11","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.wneu.2018.11.076","volume":"122","author":"R Wat","year":"2019","unstructured":"Wat R, Mammi M, Paredes J, et al. The effectiveness of antiepileptic medications as prophylaxis of early seizure in patients with traumatic brain injury compared with placebo or no treatment: a systematic review and meta-analysis. World Neurosurg. 2019;122:433\u201340. https:\/\/doi.org\/10.1016\/j.wneu.2018.11.076.","journal-title":"World Neurosurg"},{"issue":"1","key":"1599_CR12","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1097\/01.ccm.0000528950.75491.1b","volume":"46","author":"E Owen","year":"2018","unstructured":"Owen E, Creel-Bulos C, Willman M, Keeperman J. High-versus low-dose levetiracetam seizure prophylaxis for mild to moderate traumatic brain injury. Crit Care Med. 2018;46(1):455. https:\/\/doi.org\/10.1097\/01.ccm.0000528950.75491.1b.","journal-title":"Crit Care Med"},{"issue":"1","key":"1599_CR13","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1089\/neu.2015.4328","volume":"34","author":"AA Udy","year":"2017","unstructured":"Udy AA, Jarrett P, Lassig-Smith M, et al. Augmented renal clearance in traumatic brain injury: a single-center observational study of atrial natriuretic peptide cardiac output and creatinine clearance. J Neurotrauma. 2017;34(1):137\u201344. https:\/\/doi.org\/10.1089\/neu.2015.4328.","journal-title":"J Neurotrauma"},{"issue":"1","key":"1599_CR14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000180580","volume":"16","author":"DW Cockcroft","year":"1976","unstructured":"Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31\u201341. https:\/\/doi.org\/10.1159\/000180580.","journal-title":"Nephron"},{"issue":"10","key":"1599_CR15","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1177\/1060028017713294","volume":"51","author":"HJ Shiue","year":"2017","unstructured":"Shiue HJ, Taylor M, Sands KA. Comparison of levetiracetam dosing regimens in end-stage renal disease patients undergoing intermittent hemodialysis. Ann Pharmacother. 2017;51(10):862\u20135. https:\/\/doi.org\/10.1177\/1060028017713294.","journal-title":"Ann Pharmacother"},{"issue":"4","key":"1599_CR16","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1214\/19-AOAS1282","volume":"13","author":"F Li","year":"2019","unstructured":"Li F, Li F. Propensity score weighting for causal inference with multiple treatments. Annals Appl Stat. 2019;13(4):2389\u2013415.","journal-title":"Annals Appl Stat"},{"issue":"28","key":"1599_CR17","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.1002\/sim.6607","volume":"34","author":"PC Austin","year":"2015","unstructured":"Austin PC, Stuart EA. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Stat Med. 2015;34(28):3661\u201379. https:\/\/doi.org\/10.1002\/sim.6607.","journal-title":"Stat Med"},{"issue":"1","key":"1599_CR18","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12874-020-00994-0","volume":"20","author":"E Granger","year":"2020","unstructured":"Granger E, Watkins T, Sergeant JC, Lunt M. A review of the use of propensity score diagnostics in papers published in high-ranking medical journals. BMC Med Res Methodol. 2020;20(1):132. https:\/\/doi.org\/10.1186\/s12874-020-00994-0.","journal-title":"BMC Med Res Methodol"},{"issue":"24","key":"1599_CR19","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1002\/sim.8659","volume":"39","author":"A Chattopadhyay","year":"2020","unstructured":"Chattopadhyay A, Hase CH, Zubizarreta JR. Balancing vs modeling approaches to weighting in practice. Stat Med. 2020;39(24):3227\u201354.","journal-title":"Stat Med"},{"key":"1599_CR20","unstructured":"H W. Data from: ggplot2: Elegant graphics for data analysis. 2016;ISBN 978\u20133\u2013319\u201324277\u20134. Springer-Verlag New York."},{"key":"1599_CR21","doi-asserted-by":"crossref","unstructured":"Zhou T, Tong G, Li F, Thomas L, Li F. PSweight: Propensity score weighting for causal inference with observational studies and randomized trials. R package version 1.1.5.\u00a0. 2021.","DOI":"10.32614\/CRAN.package.PSweight"}],"container-title":["Neurocritical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-022-01599-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12028-022-01599-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-022-01599-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T20:03:36Z","timestamp":1728072216000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12028-022-01599-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,27]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["1599"],"URL":"https:\/\/doi.org\/10.1007\/s12028-022-01599-9","relation":{},"ISSN":["1541-6933","1556-0961"],"issn-type":[{"value":"1541-6933","type":"print"},{"value":"1556-0961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,27]]},"assertion":[{"value":"21 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The institutional review board approved the study prior to data collection and waived the need for informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval\/Informed Consent"}}]}}